0001209191-17-060277.txt : 20171113
0001209191-17-060277.hdr.sgml : 20171110
20171113161014
ACCESSION NUMBER: 0001209191-17-060277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171109
FILED AS OF DATE: 20171113
DATE AS OF CHANGE: 20171113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conroy Kevin T
CENTRAL INDEX KEY: 0001306119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35092
FILM NUMBER: 171195930
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXACT SCIENCES CORP
CENTRAL INDEX KEY: 0001124140
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 204782291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
BUSINESS PHONE: 608-284-5700
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
FORMER COMPANY:
FORMER CONFORMED NAME: EXACT CORP
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-09
0
0001124140
EXACT SCIENCES CORP
EXAS
0001306119
Conroy Kevin T
C/O EXACT SCIENCES CORP.
441 CHARMANY DRIVE
MADISON
WI
53719
1
1
0
0
President and CEO
Common Stock
2017-11-09
4
M
0
137815
0.83
A
967867
D
Common Stock
2017-11-09
4
S
0
51976
58.593
D
915891
D
Common Stock
2017-11-09
4
S
0
80405
59.431
D
835486
D
Common Stock
2017-11-09
4
S
0
5424
60.046
D
830052
D
Common Stock
24990
I
Held in 401(K) Account
Common Stock
65189
I
Held in Grantor Retained Annuity Trust
Stock Option (right to buy)
0.83
2017-11-09
4
M
0
137815
0.00
D
2013-03-18
2019-03-18
Common Stock
137815
880261
D
As previously announced by Exact Sciences Corporation in its Current Report on Form 8-K filed on August 11, 2017, the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017 which covers only the remaining portion of a stock option granted to Mr. Conroy in March 2009 that expires in March 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.93 to $58.92, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.93 to $59.92, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.93 to $60.36, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
In addition to the shares of Common Stock and options to purchase Common Stock reported on this Form 4, which total 1,800,492 shares, Mr. Conroy also holds, in the aggregate, an additional 1,125,158 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
2017-11-13